When is risk-reducing removal of the ovaries and tubes recommended for BRCA gene mutation?

This operation, often called risk-reducing salpingo-oophorectomy, removes both ovaries and fallopian tubes. It reduces the chance of cancer arising in those organs, but it cannot remove every related cancer risk. If performed before natural menopause, it causes an abrupt loss of ovarian hormones and ends the ability to become pregnant without previously stored eggs or embryos. The team may discuss symptoms, bone health, heart health, sexual wellbeing, and hormone therapy.

Ask a gynaecologic oncology and genetics team how your BRCA1 or BRCA2 result affects timing. Discuss whether you want children, fertility preservation, contraception, hormone therapy, and the plan for recovery. Review previous operations, medicines, clotting history, and other health conditions. Ask what follow-up is needed because screening is not a complete substitute for the operation when surgery is advised.

Seek assessment for persistent pelvic or abdominal pain, bloating, early fullness, unusual vaginal bleeding, or a change in bowel or bladder habits. After surgery, call the team for fever, worsening pain, wound redness, drainage, heavy bleeding, or difficulty passing urine. Emergency help is needed for collapse, severe abdominal pain, chest pain, or severe breathlessness.

How does my mutation affect the timing recommendation? What fertility-preservation options should I consider first? What symptoms can follow removal of the ovaries? Is hormone therapy suitable for me? What follow-up and support will I receive after surgery?